New COVID-19 clinical trials: 268 posted since Nov 2024

Name: New COVID-19 clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New COVID-19 clinical trials: 268 rows for $13.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 9 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/covid-19, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated October 27, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

268 clinical studies in COVID-19 were first posted on ClinicalTrials.gov from November 12, 2024 to October 27, 2026; 78 have an industry sponsor and 81 are recruiting or about to. The newest, NCT07899346, was posted on October 27, 2026: Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome (Invivyd, Inc.).

The request: Every new COVID-19 clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

268New trials
78Industry sponsored
81Recruiting or not yet
October 27, 2026Latest posted

Newest trials

The newest 100 of 268, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
October 27, 2026	NCT07899346	Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome	Invivyd, Inc.	Phase 2	Not yet recruiting	Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine, COVID Long	130		clinicaltrials.gov
October 23, 2026	NCT07892872	Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections	Capital Medical University	Not applicable	Not yet recruiting	Respiratory Viral Infections, Influenza, SARS CoV 2 Infection	618	China	clinicaltrials.gov
October 20, 2026	NCT07882186	Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the...	Assistance Publique - Hôpitaux de Paris	Observational	Not yet recruiting	Vaccination Coverage Among Pregnant Women	1,605	France	clinicaltrials.gov
October 15, 2026	NCT07875270	Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test	CorDx, Inc.	Not applicable	Not yet recruiting	SARS-CoV-2 Infection, Influenza A, Influenza B, RSV	1,500	United States	clinicaltrials.gov
October 13, 2026	NCT07871448	Flu COVID Vaccine Views	George Washington University	Observational	Not yet recruiting	Influenza, COVID-19, Vaccination Willingness	550	United States	clinicaltrials.gov
October 7, 2026	NCT07863635	A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations	ModernaTX, Inc.	Phase 4	Recruiting	SARS-CoV-2	600	United States	clinicaltrials.gov
October 6, 2026	NCT07861542	Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19	Sanofi	Phase 4	Recruiting	COVID-19	660	United States	clinicaltrials.gov
October 2, 2026	NCT07856576	Effect of a Social-Support-Based Educational Intervention on COVID-19-Related Anxiety and Perceived Social Support in Pregnant Women: A...	Atefeh Dehnoalian	Not applicable	Completed	Pregnancy, Anxiety, COVID-19, Social Support	110	Iran	clinicaltrials.gov
October 2, 2026	NCT07856225	Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer	Fundación Santa Fe de Bogota	Observational	Recruiting	Breast Neoplasms, Triple Negative Breast Neoplasms, HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast Cancer	370	Colombia	clinicaltrials.gov
September 28, 2026	NCT07845396	Assessment of Stress and Associated Factors Among Young Adults During the COVID-19 Pandemic	GCS Ramsay Santé pour l'Enseignement et la Recherche	Observational	Completed	Anxiety, Stress, COVID - 19	1,322	France	clinicaltrials.gov
September 24, 2026	NCT07838363	Online Pain Management Programmes During the Covid-19 Pandemic	Walton Centre NHS Foundation Trust	Observational	Completed	Pain Management	30	United Kingdom	clinicaltrials.gov
September 22, 2026	NCT07834073	Immunogenicity and Safety of a Single Dose of mRNA SARS-CoV-2 Vaccine in Chinese Adults With Hybrid Immunity	Jiangsu Province Centers for Disease Control and Prevention	Phase 4	Completed	COVID-19, SARS-CoV-2 Infection	2,052	China	clinicaltrials.gov
September 11, 2026	NCT07816471	RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults	Hospital Italiano de Buenos Aires	Observational	Active not recruiting	Respiratory Syncytial Virus Infections, Immunocompromised Host, Influenza, COVID - 19	350		clinicaltrials.gov
September 9, 2026	NCT07808697	A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age	ModernaTX, Inc.	Phase 2	Recruiting	SARS-CoV-2	300	Argentina, Dominican Republic, Mexico, Panama, Puerto Rico, United States	clinicaltrials.gov
September 1, 2026	NCT07798648	A Study of COVID-19 Vaccine(s) in Children and Adults	BioNTech SE	Phase 3	Recruiting	COVID-19 Vaccines	700	United States	clinicaltrials.gov
August 27, 2026	NCT07791186	Safety, Tolerability, and Immunogenicity of BMI2012 Against COVID-19 Variant in Healthy Adults Aged 19 and 55 Years	BMI Korea	Phase 1	Not yet recruiting	Prevention of COVID-19 Variant (Omicron JN.1)	72	South Korea	clinicaltrials.gov
August 27, 2026	NCT07790523	Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years	Tor Biering-Sørensen	Phase 4	Not yet recruiting	COVID-19, Influenza	410,000	Denmark, Spain	clinicaltrials.gov
August 24, 2026	NCT07781501	Long-Term Study of COVID-19 Infection and Long COVID	University of North Carolina, Chapel Hill	Observational	Recruiting	SARS CoV-2 Post-Acute Sequelae	500	United States	clinicaltrials.gov
August 14, 2026	NCT07766512	Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Long COVID, COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Post-Acute COVID-19	900		clinicaltrials.gov
August 12, 2026	NCT07760701	Description of the Lived Experiences of Family Caregivers for People With Mental Health Comorbidities	Centre for Infectious Disease Research in Zambia	Observational	Completed	Depression, Anxiety, Trauma	30	Zambia	clinicaltrials.gov
August 11, 2026	NCT07758309	Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized Studies	University of South Carolina	Not applicable	Completed	COVID-19, Vaccine Hesitancy, Health Misinformation, Communication	3,637	United States	clinicaltrials.gov
August 11, 2026	NCT07758296	An Online Game to Help Canadian Adults Identify COVID-19 Vaccine Misinformation With One-Month Follow-Up	University of South Carolina	Not applicable	Completed	COVID-19, Vaccination Hesitancy, Health Misinformation, Communication	4,071	United States	clinicaltrials.gov
August 11, 2026	NCT07757620	Epigenetic Changes in Long COVID Patients	Istituti Clinici Scientifici Maugeri SpA	Observational	Active not recruiting	Long COVID-19 Syndrome, Long COVID Symptoms	1,000	Italy	clinicaltrials.gov
August 5, 2026	NCT07746544	Study of Secutrelvir in Participants With COVID-19	Shionogi	Phase 3	Recruiting	COVID-19	1,200	Japan	clinicaltrials.gov
August 4, 2026	NCT07743970	Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia	Biocrucible Ltd	Not applicable	Active not recruiting	SARS CoV 2 Infection, Influenza A Virus Infection, Influenza B Virus Infection	500	Australia	clinicaltrials.gov
August 4, 2026	NCT07743580	A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease	Shionogi	Phase 3	Recruiting	SARS-CoV-2	2,000	Bulgaria, Japan, United States	clinicaltrials.gov
July 31, 2026	NCT07739446	Effect of Surgical Masks in Preventing Acute Respiratory Infections	Chiba University	Not applicable	Enrolling by invitation	Acute Respiratory Infections (ARIs), Influenza, COVID - 19	2,400	Japan	clinicaltrials.gov
July 28, 2026	NCT07730450	A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age	BioNTech SE	Phase 4	Recruiting	COVID-19 Vaccines	200	United States	clinicaltrials.gov
July 27, 2026	NCT07729241	COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival	Groupe Hospitalier Pitie-Salpetriere	Observational	Completed	Cancer, Immune Checkpoint Inhibitors, COVID-19 Vaccination, Survival	95,015	France	clinicaltrials.gov
July 27, 2026	NCT07728396	A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults	GC Biopharma Corp	Phase 1	Active not recruiting	COVID - 19	72	South Korea	clinicaltrials.gov
July 23, 2026	NCT07722000	Different Treatment Options Used for Post Covid-19 Syndrome	Beni-Suef University	Not applicable	Completed	COVID-19, Post COVID-19 Syndrome, Ginkgo Biloba, Piracetam	90	Egypt	clinicaltrials.gov
July 22, 2026	NCT07720596	Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era	Charles University, Czech Republic	Observational	Completed	COVID-19, SARS-CoV-2	1,795,570	Czechia	clinicaltrials.gov
July 22, 2026	NCT07719166	Treatment and Outcomes in Patients With COVID-19 and Competing Acute Surgical Diseases in Moscow	Pirogov Russian National Research Medical University	Observational	Completed	COVID-19, Emergency Surgery, Abdominal Surgery, Real-World Data	58,000	Russia	clinicaltrials.gov
July 17, 2026	NCT07711444	The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID...	National Science and Technology Council, Taiwan	Not applicable	Completed	COVID - 19, Depression - Major Depressive Disorder	54	Taiwan	clinicaltrials.gov
July 16, 2026	NCT07709637	Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients	LucasBio	Phase 1	Active not recruiting	COVID-19, COVID-19 (SARS-CoV-2 Infection)	1	South Korea	clinicaltrials.gov
July 14, 2026	NCT07703475	A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Not yet recruiting	COVID -19	80	United States	clinicaltrials.gov
July 8, 2026	NCT07690943	Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients	LucasBio	Not applicable	Completed	COVID-19, COVID-19 (SARS-CoV-2 Infection)	13	South Korea	clinicaltrials.gov
July 1, 2026	NCT07678619	Smart Analysis and Decision-Making for Emerging Infectious Diseases	Peking University	Not applicable	Enrolling by invitation	Emerging Infectious Diseases, COVID-19, Influenza, Mpox (Monkeypox), Dengue Fever, Chikungunya Fever, Avian Influenza	108	China	clinicaltrials.gov
June 24, 2026	NCT07664696	Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19...	Kimera Labs Inc.	Phase 1/2	Not yet recruiting	COVID-19	64		clinicaltrials.gov
June 22, 2026	NCT07659847	Cardiovascular Assessment 5 Years After MIS-C	Medical University of Warsaw	Observational	Recruiting	Multisystem Inflammatory Syndrome in Children (MIS-C), SARS-CoV-2 Infection	90	Poland	clinicaltrials.gov
June 18, 2026	NCT07656610	Respiratory Muscle Training and Walking Exercise in Women Recovering From COVID-19 Pneumonia	Hitit University	Not applicable	Completed	COVID-19 Pneumonia, Respiratory Symptoms	80	Turkey (Türkiye)	clinicaltrials.gov
June 17, 2026	NCT07655180	Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine	Invivyd, Inc.	Phase 3	Completed	COVID-19	210	United States	clinicaltrials.gov
June 16, 2026	NCT07651761	Patient-Centered Practical Vaccine Talk For Busy Clinicians	University of Massachusetts, Worcester	Not applicable	Enrolling by invitation	Influenza, COVID-19	24,500	United States	clinicaltrials.gov
June 11, 2026	NCT07643688	Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections	Fabiana Sherine Ganem dos Santos	Observational	Not yet recruiting	SARS CoV 2 Infection, RSV Infections, Influenza Infection	150		clinicaltrials.gov
June 10, 2026	NCT07640308	Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster	The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)	Phase 1	Not yet recruiting	Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus)	90		clinicaltrials.gov
June 8, 2026	NCT07633366	BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics	Medical University of Vienna	Observational	Recruiting	ARDS (Acute Respiratory Distress Syndrome)	130	Austria	clinicaltrials.gov
June 4, 2026	NCT07627815	Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID	ParagonClinicals Inc.	Phase 2	Recruiting	Long COVID	82	Canada	clinicaltrials.gov
May 28, 2026	NCT07610512	Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines	Grape King Bio Ltd.	Not applicable	Completed	COVID-19, Immune Response	138	Taiwan	clinicaltrials.gov
May 20, 2026	NCT07599449	Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France	Institut National de la Santé Et de la Recherche Médicale, France	Observational	Recruiting	Respiratory Tract Infections (RTI), Influenza -Like Illness, Influenza, COVID - 19, RSV Infections, Rhinovirus...	25,000	France	clinicaltrials.gov
May 19, 2026	NCT07597889	Diagnostic Accuracy of 2 cm Versus 4 cm Insertion Depth for Nasal Swabs for SARS-CoV-2 (COVID-19) Rapid Antigen Testing-A Randomized...	Copenhagen University Hospital, Rigshospitalet	Not applicable	Completed	COVID -19	317	Denmark	clinicaltrials.gov
May 19, 2026	NCT07597876	SMAtteo COvid19 REgistry (SMACORE)	Fondazione IRCCS Policlinico San Matteo di Pavia	Observational	Recruiting	COVID-19	1,000	Italy	clinicaltrials.gov
May 6, 2026	NCT07571421	Effect of a Visual Educational Intervention on Dental Anxiety in Children	Istanbul University	Not applicable	Completed	Dental Anxiety in Children	70	Turkey (Türkiye)	clinicaltrials.gov
May 6, 2026	NCT07569523	Development of Preterm Infants Born During the COVID-19 Pandemic	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Observational	Not yet recruiting	Preterm Infant Development, COVID - 19	120		clinicaltrials.gov
April 30, 2026	NCT07560059	Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)	Algerian Society of Diabetology	Observational	Completed	Diabetes Mellitus, COVID-19, Post-Acute COVID-19 Syndrome	201	Algeria	clinicaltrials.gov
April 27, 2026	NCT07552779	A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir	Pfizer	Phase 1	Completed	Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), COVID-19 (Coronavirus Disease 2019), Upper Respiratory...	17	Belgium	clinicaltrials.gov
April 17, 2026	NCT07536308	A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in...	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Active not recruiting	COVID-19	83	United States	clinicaltrials.gov
April 14, 2026	NCT07527130	C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome	Mayo Clinic	Observational	Not yet recruiting	COVID-19	10	United States	clinicaltrials.gov
April 9, 2026	NCT07518771	PA-001 Ph.1 Study in Healthy and Elderly Subjects	PeptiDream Inc.	Phase 1	Completed	COVID - 19	47	United States	clinicaltrials.gov
April 8, 2026	NCT07516977	Noseguard for Prevention of Respiratory Infections in Real-World Use	Daewoong Pharmaceutical Co. LTD.	Not applicable	Not yet recruiting	Respiratory Infection Virus, COVID-19, Influenza	2,000	South Korea	clinicaltrials.gov
April 1, 2026	NCT07505953	The Effects of Operating Room COVID-19 Personal Protective Equipment on Speech Perception and Listening Effort	Ondokuz Mayıs University	Observational	Completed	Speech Perception, Communication Barriers, Operating Rooms, Protective Devices	219	Turkey (Türkiye)	clinicaltrials.gov
March 31, 2026	NCT07504341	Physiological Finding in Management of COVID 19 Patients	St. Martin De Porress Hospital	Observational	Recruiting	COVID-19 (Coronavirus Disease 2019)	15,000	Taiwan	clinicaltrials.gov
March 24, 2026	NCT07490314	Blood Product Supply	Methodist Health System	Observational	Completed	COVID-19	100	United States	clinicaltrials.gov
March 12, 2026	NCT07466524	suPAR Michigan M2C2 Heterogeneity Validation Cohort Study	ViroGates A/S	Observational	Completed	COVID-19, Severe Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome	367	United States	clinicaltrials.gov
March 11, 2026	NCT07464314	A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults	GlaxoSmithKline	Phase 1	Recruiting	Influenza, Human+COVID-19	225	United States	clinicaltrials.gov
March 5, 2026	NCT07450833	Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers	Benfovir AG	Phase 1	Completed	Healthy Volunteers	48	Bulgaria	clinicaltrials.gov
March 3, 2026	NCT07445971	A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.	ModeX Therapeutics, An OPKO Health Company	Phase 1	Recruiting	COVID -19, COVID-19 (Prevention)	80	United States	clinicaltrials.gov
February 27, 2026	NCT07436572	Neural Network-Based Prediction in Critical COVID-19 Patients	University of Gaziantep	Observational	Completed	COVID-19 Pandemic	113	Turkey (Türkiye)	clinicaltrials.gov
February 27, 2026	NCT07436494	Coronavirus Anxiety in Patients Using Biologic vs Conventional DMARDs	Bursa City Hospital	Observational	Completed	COVID-19, Anxiety, Rheumatic Diseases	200	Turkey (Türkiye)	clinicaltrials.gov
February 24, 2026	NCT07430410	Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test	CorDx, Inc.	Not applicable	Not yet recruiting	SARS-CoV-2 Infection, Influenza A, Influenza B	200		clinicaltrials.gov
February 18, 2026	NCT07416539	Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19	Rokote Laboratories Finland Oy	Phase 1	Active not recruiting	COVID - 19, SARS CoV-2	20	Finland	clinicaltrials.gov
February 17, 2026	NCT07412574	Vitamin E Supplementation As Adjunctive Therapy To Lower Inflammation In COVID-19 Patients	Universidad Veracruzana	Early phase 1	Completed	COVID - 19	56	Mexico	clinicaltrials.gov
February 13, 2026	NCT07408297	Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in...	Victoria Biomedical Research Institute	Phase 2	Completed	COVID -19, SARS CoV 2 Infection	1,919	Kenya	clinicaltrials.gov
February 12, 2026	NCT07406217	OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients	Calmy Alexandra	Phase 2	Recruiting	COVID-19, Immunodeficiency	256	Switzerland	clinicaltrials.gov
February 9, 2026	NCT07397455	Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants	Imperial College London	Phase 1	Recruiting	SARS-CoV-2 (COVID-19)	38	United Kingdom	clinicaltrials.gov
February 9, 2026	NCT07397156	Long-Term Outcomes After ICU-Treated COVID-19 ARDS	University in Zielona Góra	Observational	Completed	COVID-19, ARDS (Acute Respiratory Distress Syndrome)	283	Poland	clinicaltrials.gov
February 5, 2026	NCT07388550	Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 1	Not yet recruiting	Post-Acute COVID-19 Syndrome	15	United States	clinicaltrials.gov
February 4, 2026	NCT07387211	Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region	The Institute of Molecular and Translational Medicine, Czech Republic	Not applicable	Completed	SARS-CoV-2, SARS-CoV-2 (COVID-19) Infection	2,484	Czechia	clinicaltrials.gov
January 20, 2026	NCT07352462	Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath	Hospices Civils de Lyon	Not applicable	Not yet recruiting	Respiratory Infections, COVID-19, Influenza Virus Infection, Legionella Pneumophila Infections	777	France	clinicaltrials.gov
January 20, 2026	NCT07352072	Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal...	Copenhagen University Hospital, Rigshospitalet	Observational	Not yet recruiting	VV ECMO, Bleeding, Thrombosis, Transfusion Adverse Reaction, COVID-19	50	Denmark	clinicaltrials.gov
January 13, 2026	NCT07337382	The Optimising Isolation, Quarantine and Distancing Study for COVID-19	Macfarlane Burnet Institute for Medical Research and Public Health Ltd	Observational	Active not recruiting	COVID19	1,000	Australia	clinicaltrials.gov
January 9, 2026	NCT07328399	Impact of COVID-19 Pandemic Waves on Colorectal Cancer Stage Migration and Diagnostic Delays	University of Pecs	Observational	Completed	Colorectal Cancer	198	Hungary	clinicaltrials.gov
January 2, 2026	NCT07314905	Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)	Unity Health Toronto	Phase 3	Recruiting	Influenza A, Influenza B, SAR-CoV-2, Acute Respiratory Infections (ARIs)	264	Canada	clinicaltrials.gov
January 2, 2026	NCT07314593	Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.	Landspitali University Hospital	Not applicable	Recruiting	Respiratory Infections	400	Iceland	clinicaltrials.gov
December 29, 2025	NCT07308158	Covid Flu A/B and RSV 4 in 1 Diagnostic Test	iHealth Labs inc	Observational	Completed	Influenza A, Influenza B, COVID - 19, RSV	1,119	Puerto Rico, United States	clinicaltrials.gov
December 24, 2025	NCT07302295	Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period	Hospices Civils de Lyon	Not applicable	Recruiting	Suicidality, COVID -19	6,500	France	clinicaltrials.gov
December 24, 2025	NCT07300839	A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age	BioNTech SE	Phase 3	Completed	COVID-19, SARS-COV-2 Infection	5,240	United States	clinicaltrials.gov
December 23, 2025	NCT07298434	Study of VYD2311 for the Prevention of COVID-19	Invivyd, Inc.	Phase 3	Active not recruiting	COVID-19	1,770	United States	clinicaltrials.gov
December 17, 2025	NCT07287137	Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study	Henry M. Jackson Foundation for the Advancement of Military Medicine	Phase 4	Recruiting	COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus, Respiratory Viruses, Respiratory Virus Infection...	54	United States	clinicaltrials.gov
December 12, 2025	NCT07279766	Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors...	Tor Biering-Sørensen	Phase 4	Completed	COVID-19	41,060	Denmark	clinicaltrials.gov
December 5, 2025	NCT07266558	A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions...	ModernaTX, Inc.	Phase 4	Active not recruiting	SARS-CoV-2	30,000	United States	clinicaltrials.gov
December 3, 2025	NCT07262450	Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms	Laboratoire de la Mer	Not applicable	Recruiting	URTI, Bronchiolitis, COVID - 19, Allergic Rhinitis, Chronic Rhinosinusitis (CRS), Post-surgery	1,065	France	clinicaltrials.gov
December 3, 2025	NCT07261085	A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.	Pfizer	Observational	Completed	COVID-19	99,000	United States	clinicaltrials.gov
November 28, 2025	NCT07254442	Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing	Zonguldak Bulent Ecevit University	Observational	Completed	Hearing, COVID - 19, Ototoxicity	90	Turkey (Türkiye)	clinicaltrials.gov
November 25, 2025	NCT07248319	Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases...	Lebanese American University	Not applicable	Not yet recruiting	Produce and Evaluate an Evidence-based Health Awareness Video	160	Lebanon	clinicaltrials.gov
November 24, 2025	NCT07244731	The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients	Ankara University	Observational	Completed	COVID - 19, Prognosis, ICU	146	Turkey (Türkiye)	clinicaltrials.gov
November 19, 2025	NCT07235137	A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults	Pfizer	Phase 1	Completed	Healthy Participant	12	China	clinicaltrials.gov
October 29, 2025	NCT07222384	A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at...	BioNTech SE	Phase 3	Completed	COVID-19, SARS-COV-2 Infection	344	Puerto Rico, United States	clinicaltrials.gov
October 27, 2025	NCT07221162	A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Active not recruiting	COVID-19	140	United States	clinicaltrials.gov
October 16, 2025	NCT07217639	Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings	Aptitude Medical Systems	Not applicable	Not yet recruiting	COVID -19, Influenza A, Influenza B, Respiratory Synctial Virus, RSV, Rhinovirus	2,000	United States	clinicaltrials.gov
October 10, 2025	NCT07215520	Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults	CastleVax Inc.	Phase 2	Active not recruiting	COVID-19	200	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Pfizer	11	April 27, 2026
National Institute of Allergy and Infectious Diseases (NIAID)	8	July 14, 2026
BioNTech SE	7	September 1, 2026
ModernaTX, Inc.	6	October 7, 2026
Shionogi	5	August 5, 2026
Invivyd, Inc.	3	October 27, 2026
Assistance Publique - Hôpitaux de Paris	3	October 20, 2026
Centre for Infectious Disease Research in Zambia	3	August 12, 2026
Fondazione IRCCS Policlinico San Matteo di Pavia	3	May 19, 2026
Hospices Civils de Lyon	3	January 20, 2026
Ankara University	3	November 24, 2025
CorDx, Inc.	2	October 15, 2026
Sanofi	2	October 6, 2026
Tor Biering-Sørensen	2	August 27, 2026
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	2	August 14, 2026
University of South Carolina	2	August 11, 2026
Beni-Suef University	2	July 23, 2026
LucasBio	2	July 16, 2026
Institut National de la Santé Et de la Recherche Médicale, France	2	May 20, 2026
Copenhagen University Hospital, Rigshospitalet	2	May 19, 2026

By phase

Phase	New trials	Latest
Observational	105	October 20, 2026
Not applicable	69	October 23, 2026
Phase 1	34	August 27, 2026
Phase 2	18	October 27, 2026
Phase 3	18	September 1, 2026
Phase 4	11	October 7, 2026
Phase 1/2	9	June 24, 2026
Early phase 1	3	February 17, 2026
Phase 2/3	1	August 14, 2025

By country

Country	New trials	Latest
United States	83	October 15, 2026
Turkey (Türkiye)	22	June 18, 2026
France	18	October 20, 2026
China	16	October 23, 2026
Italy	15	August 11, 2026
Spain	14	August 27, 2026
South Korea	9	August 27, 2026
Taiwan	7	July 17, 2026
Japan	6	August 5, 2026
Brazil	6	September 30, 2025
Puerto Rico	5	September 9, 2026
Denmark	5	August 27, 2026
Canada	5	June 4, 2026
Zambia	4	August 12, 2026
Egypt	4	July 23, 2026
Colombia	3	October 2, 2026
United Kingdom	3	September 24, 2026
Argentina	3	September 9, 2026
Mexico	3	September 9, 2026
Australia	3	August 4, 2026
Czechia	3	July 22, 2026
Russia	3	July 22, 2026
Poland	3	June 22, 2026
Belgium	3	April 27, 2026
Switzerland	3	February 12, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.